You don't think K pill could be done for less since we know it was supposedly already half way thru toxicology testing when put on hold last year? Once we get that K is ready to be partnered out for big bucks as I don't think IPIX will want to handle the hassle of the many complementary trials, the overall size of the project, and the fact that a good BP could bring this needed technology to market so much faster IMO!

Nice problem for IPIX mgt to have, not having to find a great project but instead having to find the rollout order for a number of great projects.

Topical creams for dermatology should also be a very easy step to accomplish.